Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

Market Cap	2.87B -5.0%
Revenue (ttm)	886.96M -14.9%
Net Income	43.95M +79.6%
EPS	0.14 +79.6%
Shares Out	303.35M
PE Ratio	65.36
Forward PE	n/a
Dividend	0.04 (0.42%)
Ex-Dividend Date	n/a

Volume	6,904,750
Average Volume	7,598,130
Open	9.14
Previous Close	9.47
Day's Range	9.14 - 9.59
52-Week Range	8.56 - 12.90
Beta	0.65
RSI	49.73
Earnings Date	Apr 3, 2026

About SHE:300534

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It is also involved in the cultivation, processing, and sales of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002 and is based in Lanzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 641
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300534

Financial Performance

In 2025, SHE:300534's revenue was 886.96 million, a decrease of -14.92% compared to the previous year's 1.04 billion. Earnings were 43.95 million, an increase of 79.56%.